Cytek Biosciences IncCTKB

CTKB current price
$6.48-31.28%

Capital at risk.

1W
+2.37%
1M
-0.61%
3M
+24.62%
6M
+18.03%
1Y
-31.28%
MAX
-65.46%
About Cytek Biosciences Inc
Ticker
info
CTKB
Trading on
info
NASDAQ
ISIN
info
US23285D1090
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Dr. Wenbin Jiang Ph.D.
Headquarters
info
47215 Lakeview Boulevard, Fremont, CA, United States, 94538
Employees
info
645
Website
info
https://cytekbio.com
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Metrics
BasicAdvanced
Market cap
info
$836M
P/E ratio
info
-
EPS
info
-$0.08
Dividend Yield
info
0.00%
Beta
info
1.32
Forward P/E ratio
info
370.37
EBIDTA
info
$-15.2M
Ex dividend date
info
-
Price & volume
Market cap
info
$836M
Average daily volume
info
0.6M
90-day return
info
24.62%
30-day return
info
-0.61%
7-day return
info
2.37%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
370.37
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
4.15
Price to book
info
2.17
Earnings
EPS
info
-$0.08
EPS estimate (current quarter)
info
-$0.01
EPS estimate (next quarter)
info
$0.05
EBITDA
info
$-15.2M
Revenues (TTM)
info
$201M
Revenues per share (TTM)
info
$1.53
Technicals
Beta
info
1.32
52-week High
info
$9.52
52-week Low
info
$4.66
50-day moving average
info
$6.06
200-day moving average
info
$5.92
Short ratio
info
4.5
Short %
info
3.95%
Management effectiveness
ROE (TTM)
info
2.54%
ROA (TTM)
info
2.74%
Profit margin
info
5.05%
Gross profit margin
info
$101M
Operating margin
info
8.25%
Growth
Quarterly earnings growth (YoY)
info
65.80%
Quarterly revenue growth (YoY)
info
7.30%
Share stats
Outstanding Shares
info
129M
Float
info
111M
Insiders %
info
8.85%
Institutions %
info
59.02%
Analyst Insights & forecasts
info

67% Buy

33% Hold

0% Sell

Based on information from 6 analysts.

Average price target

info
$8.40
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.04
$0.01
300.00%
Q4 • 23Beat
-$0.05
-$0.04
25.00%
Q1 • 24Beat
-$0.08
-$0.03
166.67%
Q2 • 24Beat
$0.06
$0.04
52.04%
Q3 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$46.6M
$-10.4M
22.38%
Q2 • 24
$51.5M
$0.9M
1.83%
Q3 • 24
10.47%
109.02%
108.16%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$484M
$94.6M
19.56%
Q2 • 24
$491M
$106M
21.53%
Q3 • 24
1.55%
11.80%
10.09%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$6.2M
$2M
$-1.7M
$5M
Q2 • 24
$13.2M
-
$-12.1M
$12.4M
Q3 • 24
113.10%
-
606.25%
148.11%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Cytek Biosciences Inc share?
Collapse

Cytek Biosciences Inc shares are currently traded for $6.48 per share.

How many shares does Cytek Biosciences Inc have?
Collapse

Cytek Biosciences Inc currently has 129M shares.

Does Cytek Biosciences Inc pay dividends?
Collapse

No, Cytek Biosciences Inc doesn't pay dividends.

What is Cytek Biosciences Inc 52 week high?
Collapse

Cytek Biosciences Inc 52 week high is $9.52.

What is Cytek Biosciences Inc 52 week low?
Collapse

Cytek Biosciences Inc 52 week low is $4.66.

What is the 200-day moving average of Cytek Biosciences Inc?
Collapse

Cytek Biosciences Inc 200-day moving average is $5.92.

Who is Cytek Biosciences Inc CEO?
Collapse

The CEO of Cytek Biosciences Inc is Dr. Wenbin Jiang Ph.D..

How many employees Cytek Biosciences Inc has?
Collapse

Cytek Biosciences Inc has 645 employees.

What is the market cap of Cytek Biosciences Inc?
Collapse

The market cap of Cytek Biosciences Inc is $836M.

What is the P/E of Cytek Biosciences Inc?
Collapse

The current P/E of Cytek Biosciences Inc is null.

What is the EPS of Cytek Biosciences Inc?
Collapse

The EPS of Cytek Biosciences Inc is -$0.08.

What is the PEG Ratio of Cytek Biosciences Inc?
Collapse

The PEG Ration of Cytek Biosciences Inc is null.

What do analysts say about Cytek Biosciences Inc?
Collapse

According to the analysts Cytek Biosciences Inc is considered a buy.